Startup fundraising and exits look bullish for bio and health

 After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor was it a company on the list of known unicorns. And it had nothing to do with blockchain. Read More

Responses are currently closed, but you can trackback from your own site.

Comments are closed.